Lim Jonathan E

CIK 00012832905 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283290

Recent Transactions

50 trades

Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 total
Award
Boundless Bio, Inc.$BOLD
Stock Option (right to buy)
2025-06-23+24,000→ 24,000 total
Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-02-03+270,232→ 307,956 total
Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-02-03+37,724→ 37,724 total
Conversion
Maze Therapeutics, Inc.$MAZE
Series A Preferred Stock
2025-02-03−363,703→ 0 total
Conversion
Maze Therapeutics, Inc.$MAZE
Series B Preferred Stock
2025-02-03−2,231,381→ 0 total
Award
Erasca, Inc.$ERAS
Stock option (right to buy)
2025-02-03+2,500,000→ 2,500,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+9,086→ 9,086 total
Disposition to Issuer
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09−5,704→ 0 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+5,704→ 5,704 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2024-06-20+632,759→ 632,759 total
Award
Boundless Bio, Inc.$BOLD
Stock Option (Right to Buy)
2024-06-20+6,610→ 6,610 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+525,274→ 550,915 total
Conversion
Boundless Bio, Inc.$BOLD
Series B Convertible Preferred Stock
2024-04-02−5,128→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series C Convertible Preferred Stock
2024-04-02−7,326→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−512,820→ 0 total
Award
Boundless Bio, Inc.$BOLD
Stock Option
2024-03-27+13,219→ 13,219 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2024-02-05+1,500,000→ 1,500,000 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-12-06$1.72/sh+278,150→ 12,899,360 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-12-05$1.69/sh+721,850→ 12,899,360 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-10-05$2.03/sh+1,000,000→ 19,456,216 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-06-08$2.75/sh+100,000→ 18,396,216 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-03-28$2.84/sh+100,000→ 18,296,216 total
Award
Erasca, Inc.$ERAS
Stock Option (right to buy)
2023-02-01+1,500,000→ 1,500,000 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2023-01-10$3.86/sh+60,000→ 20,256,222 total
Purchase
Erasca, Inc.$ERAS
Common Stock
2022-12-14$4.99/sh+40,000→ 20,196,222 total
Gift
Erasca, Inc.$ERAS
Common Stock
2022-11-30−2,000,006→ 18,196,216 total
Award
Erasca, Inc.$ERAS
Stock Option (Right to Buy)
2022-02-01+791,000→ 791,000 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,135,390→ 20,156,222 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,162,468→ 0 total
Conversion
Erasca, Inc.$ERAS
Series B-1 Preferred Stock
2021-07-20−336,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Series B-2 Preferred Stock
2021-07-20−112,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,441,027→ 11,899,360 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,081,233→ 0 total
Disposition to Issuer
Ignyta, Inc.
Stock Option (Right to Buy)
2018-02-08−400,000→ 0 total
Disposition to Issuer
Ignyta, Inc.
Stock Option (Right to Buy)
2018-02-08−120,000→ 0 total
Disposition to Issuer
Ignyta, Inc.
Stock Option (Right to Buy)
2018-02-08−100,000→ 0 total
Disposition to Issuer
Ignyta, Inc.
Common Stock
2018-02-08$27.00/sh−179,661→ 0 total
Disposition to Issuer
Ignyta, Inc.
Common Stock
2018-02-08$27.00/sh−3,350,000→ 0 total
Tax Payment
Ignyta, Inc.
Common Stock
2017-12-26$26.70/sh−19,006→ 179,661 total
Award
Ignyta, Inc.
Common Stock
2017-12-22+68,334→ 198,667 total
Award
Ignyta, Inc.
Common Stock
2017-12-22+68,334→ 198,667 total
Exercise/Conversion
Ignyta, Inc.
Stock Option (Right to Buy)
2017-02-13−6,945→ 0 total
Exercise/Conversion
Ignyta, Inc.
Common Stock
2017-02-13$0.60/sh+6,945→ 130,333 total
Award
Ignyta, Inc.
Stock Option (Right to Buy)
2017-01-05+120,000→ 120,000 total
Exercise/Conversion
Ignyta, Inc.
Stock Option (Right to Buy)
2016-04-11−26,388→ 6,945 total
Exercise/Conversion
Ignyta, Inc.
Common Stock
2016-04-11$0.60/sh+26,388→ 123,388 total
Purchase
Ignyta, Inc.
Common Stock
2016-03-17$5.51/sh+24,852→ 3,350,000 total
Award
Ignyta, Inc.
Common Stock
2016-01-07+72,000→ 97,000 total
Purchase
Ignyta, Inc.
Common Stock
2015-08-20$12.77/sh+40→ 3,325,148 total

Companies

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121

View on SEC.gov